Investing.com - Laboratory America reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Laboratory America announced earnings per share of $6.13 on revenue of $3.84B. Analysts polled by Investing.com anticipated EPS of $5.62 on revenue of $3.61B.
Laboratory America shares are up 10% from the beginning of the year and are trading at $283.19 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 16.53% from the start of the year.
Laboratory America follows other major Healthcare sector earnings this month
Laboratory America's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar